What began as a crisis-driven response to the Covid pandemic laid the foundation for today’s dominant management paradigm: ...
Recently closed $50 million underwritten offering reinforces strong institutional investor conviction and bolsters balance sheet for execution of second Phase 3 HLP003 trial1- 2,3, EMBRACE, for potent ...